PAREXEL has introduced a new, dedicated division to support emerging biotech companies in reaching their drug development and commercialization goals. PAREXEL Biotech builds on the company’s clinical, regulatory, commercial and technology services with enhanced strategic consulting and asset development capabilities, offering a new Biotech-focused team and organizational structure for customers. Led by James Anthony, Global Head of Biotech, and Graciela Racaro, Global Head of Biotech Operations,...